Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer. - Dowlati A; Chapman R; Subbiah S; Fu P; Ness A; Cortas T; Patrick L; Reynolds S; Xu N; Levitan N; Ivy P; Remick SC (Investigational new drugs, 2005)